NCT04398511View on ClinicalTrials.gov

L Brevis for Traumatic Oral Lesions in Orthodontic Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 7, 2019

Primary Completion Date

November 29, 2019

Study Completion Date

December 13, 2019

Conditions
Orthodontic Appliance ComplicationOral MucositisBacterium; Agent
Interventions
DRUG

L brevis

Lactobacillus brevis CD2 lozenges (4 billion CFU) after breakfast, lunch and dinner for 21 days.

DRUG

Placebo

Placebo lozenges after breakfast, lunch and dinner for 21 days.

Trial Locations (1)

99052-900

Post-Graduate Program in Dentistry, Passo Fundo

All Listed Sponsors
collaborator

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

OTHER_GOV

lead

Universidade de Passo Fundo

OTHER

NCT04398511 - L Brevis for Traumatic Oral Lesions in Orthodontic Patients | Biotech Hunter | Biotech Hunter